Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × Nelfinavir × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vulvar Neoplasms 1 Sarcoma, Kaposi 1 Prostate Cancer Recurrent 1 Ovarian Neoplasms 1

Interventions

Nivolumab 4 pomalidomide 2 pembrolizumab 2 liposomal doxorubicin 2 Specimen Handling 2 Propranolol 2 Magnetic Resonance Spectroscopy 2 lenvatinib 1 ixazomib 1 cabozantinib 1 abemaciclib 1 Paclitaxel 1 Nelfinavir 1 NHS-IL12 immunocytokine 1 Ipilimumab 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03077451 2025-12-17

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Completed

36 enrolled 13 charts

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡